The coronavirus has accelerated the U.S. dependence on overseas manufacturing for finished dose products, as well as the active pharmaceutical ingredients necessary to produce life-saving medications.
Intelligence for the Dealmaking Community since 1965
After clicking on a story, use the back arrow in your browser to return to your search results. Use phrases "in quotes" or the tools below to better filter your results.